Accelerating the development of molecular diagnostic platforms for decentralized diagnosis of acute respiratory illness

Hi All

If anyone is working on late stage development of POC platforms for acute respiratory illness, you might be interested in this call.


Executive summary

• FIND, the global alliance for diagnostics, is leading a Request for Proposals (RFP) to accelerate the development, manufacturing, and launch of point-of-care, multi-pathogen, molecular diagnostic platforms (“POC MDx”) for use in low- and middle-income countries (LMICs). This RFP has been prepared in the context of the Access to COVID-19 Tools Accelerator (ACT-A) Diagnostics Pillar*.

• The short-term areas of focus for this RFP are: (1) suitability of the platform for use in decentralized settings, and (2) differential detection of respiratory pathogens, including COVID-19.

• A long-term goal of this RFP is to increase access to critical molecular tests,such as HIV viral load and detection of tuberculosis, by accelerating the availability of POC MDx in LMICs.

• A budget envelope of USD$25 million is available to selected manufacturers to enable development of a platform that meets a set of predefined key product requirements.

• Suppliers are expected to commit to supplying an affordable product to the public sector in LMICs and to submit a dossier for regulatory authorization by the World Health Organization Prequalification Programme.